Single-dose parvo treatment gets USDA approvalMay 3, 2023Elanco’s Canine Parvovirus Monoclonal Antibody treatment may provide a less intensive solution by targeting the virus with single-dose efficacy in dogs.
SPONSORED CONTENTFind success with your parvovirus protocolDiscover our Canine Parvovirus Monoclonal Antibody: puppies treated with CPMA experienced a 93% real-world survival rate, and were able to head home from the clinic almost two days earlier.1,2 + Read More
Parvo kills dozens of pups in MichiganAugust 25, 2022As many as 60 unvaccinated dogs in northern Michigan have died of parvovirus in recent weeks, the Michigan Department of Agriculture and Rural Development (MDARD) reports.
Canine parvovirus and care (even on a budget)November 17, 2021Puppies infected with canine parvovirus are a common presentation to veterinary practitioners.
Parvo preventative picks up speedDecember 29, 2020Elanco Animal Health is set to acquire the global rights to Kindred Biosciences’ proprietary KIND-030, a monoclonal antibody being developed for the treatment and prevention of canine parvovirus.
Parvo cases jump a whopping 70 percent during COVIDJuly 6, 2020BluePearl Specialty and Emergency Pet Hospital reports an “alarming” increase in the number of confirmed parvoviral enteritis cases and hospitalizations during the pandemic.
